MedTrace Logo

Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients

NCT03347656 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164

Last updated 2024-08-20

No results posted yet for this study

Summary

The primary aim of the study is to assess the mobility dose in neurocritical care patients with ischemic stroke or intracranial hemorrhage and its effects on discharge disposition and patient outcomes. The investigators hypothesize that patients' mobilization dose in the intensive care unit (ICU) predicts discharge disposition, 90 day Barthel Index and other outcomes like muscle wasting (expressed as decrease in rectus femoris cross sectional area (RF-CSA) in the paretic and non-paretic limb measured by bedside ultrasound), and ICU length of stay (LOS).

Conditions

  • Sarcopenia
  • Stroke, Acute
  • Muscle Weakness
  • Critical Illness

Sponsors & Collaborators

Principal Investigators

  • Balachundhar Subramaniam, MD, MPH · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2019-12-20
Completion
2021-06-30

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03347656 on ClinicalTrials.gov